<?xml version="1.0" encoding="UTF-8"?>
<p id="par0090">About 25 % of WNV-infected individuals develop West Nile fever, a clinical condition with variable symptoms and severity. In less than 1% of the infected individuals, WNV invades the central nervous system (CNS), causing neurological manifestations (neuroinvasive disease), including meningitis, encephalitis, and acute flaccid paralysis. Of note, West Nile neuroinvasive disease shows a 10%â€“20% fatality rate. Severe illness is associated with older age and other factors, including genetic traces (
 <xref rid="bib1140" ref-type="bibr">Petersen et al., 2013</xref>; 
 <xref rid="bib1320" ref-type="bibr">Sejvar, 2016</xref>). WNV infection is considered the leading cause of arboviral encephalitis in the world (
 <xref rid="bib0265" ref-type="bibr">Ciota, 2017</xref>). The treatment of WNV infection is supportive (
 <xref rid="bib1140" ref-type="bibr">Petersen et al., 2013</xref>).
</p>
